|
|
|
prIME Oncology invites you to view exciting news released from the San Antonio Breast Cancer Symposium.
|
| |
|
10 DECEMBER 2009
|
 |
|
This expert interview with Hope Rugo, MD, from the UCSF Carol Franc Buck Breast Care Center in San Francisco, California, and Julie Doughty, MD, FRCS, from the Western Infirmary in Glasgow, Scotland, along with a special newsflash and downloadable slides, discusses the topic of adjuvant endocrine therapy focusing on the following data releases:
Abstract #12: Disease Related Outcome with Long Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study (IES)
Abstract #13: Outcomes of Women Who Were Premenopausal at Diagnosis of Early Stage Breast Cancer in the NCIC CTG MA.17 Trial
Abstract #16: Adjusting for Selective Crossover in Analyses of Letrozole (Let) Versus Tamoxifen (Tam) in the BIG 1-98 Trial
Abstract #805: Rheumatologic Evaluation of Adjuvant Letrozole in Post-Menopausal Breast Cancer Patients Discontinuing Anastrozole Due to Grade 2-3 Arthralgia – Myalgia
View the eNewsflash from this data release
View the Expert Interview and Opinion with Hope Rugo, MD, and Julie Doughty, MD, FRCS and access the downloadable slides
|
| |
|
11 DECEMBER 2009
|
 |
|
View an eNewsflash and downloadable slide deck from José Baselga, MD, on newly released data from the SOLTI-0701 trial.
Abstract #45: SOLTI-0701:
A Multinational Double-Blind, Randomized Phase 2b Study Evaluating the
Efficacy and Safety of Sorafenib Compared to Placebo When Administered
in Combination with Capecitabine in Patients with Locally Advanced or
Metastatic Breast Cancer (BC)
View the eNewsflash from this data release
View downloadable slides
|
 |
|
This expert interview with William J. Gradishar, MD, from the Feinberg School of Medicine at Northwestern University in Chicago, Illinois, and Nigel Bundred, MD, FRCS, from University Hospital of South Manchester in Manchester, United Kingdom, along with a special newsflash and downloadable slide deck, discusses the topic of bone health focusing on the following data releases:
Abstract #21: Oral Bisphosphonate and Breast Cancer: Prospective Results from the Women's Health Initiative (WHI)
Abstract #27: Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
Abstract #22: A Comparison of Denosumab Versus Zoledronic Acid on the Incidence of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases
Abstract #2009: Randomised Placebo Controlled Trial Studying Short Term Biological Effects of the Combination of Letrozole and Zoledronic Acid on Invasive Breast Cancer
Abstract #4083: The Effect of Zoledronic Acid on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The Z-FAST Study 5-Year Final Follow-Up
Abstract #5046: Medical ozone (O3) oil or Gas Applications Heal osteonecrosis of the Jaw (ONJ) in Patients Treated with Bisphosphonates (BPs). Preliminary Results of a Single arm Study
View the eNewsflash from this data release
View the Expert Interview and Opinion with William J. Gradishar, MD, and Nigel Bundred, MD, FRCS, and access the downloadable slides
|
| |
|
|
 |
|
|
|
|
|
